Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion type Assertion NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_head.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion description "[In particular, the triple-negative breast cancer (TNBC), characterized by a receptor negative pattern (ER/PgR/HER2-negative) and poor prognosis, can represent one of the most relevant clinical and public health priority in terms of observational research.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_provenance.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion evidence source_evidence_literature NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_provenance.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion SIO_000772 25413873 NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_provenance.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion wasDerivedFrom befree-2016 NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_provenance.
- NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_assertion wasGeneratedBy ECO_0000203 NP1239006.RAOvmvhO-0SxllQZLKI0nir2TsqQ-6uobLde02sKW5e6I130_provenance.